Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease.

BACKGROUND Both hyperinsulinemia and microalbuminuria have been shown to increase coronary heart disease (CHD) risk, but the interaction among hyperinsulinemia, microalbuminuria, and the risk for CHD has not been investigated in previous studies. METHODS AND RESULTS The risk of CHD in relation to hyperinsulinemia and microalbuminuria was examined in a cohort of 1069 elderly nondiabetic subjects from Kuopio, east Finland, during 3.5 years of follow-up. The overall incidence of CHD death was 2.8%, and 6.9% of study subjects died of CHD or had a nonfatal myocardial infarction (later referred to as all CHD events). In the highest fasting-insulin quintile (fasting insulin > or = 114.0 pmol/L), there was a slightly but insignificantly higher incidence rate of both CHD mortality and all CHD events compared with lower quintiles. The incidence rates of CHD mortality and all CHD events were significantly higher in the highest urinary albumin/creatinine ratio (ACR) quintile (ACR > or = 3.22 mg/mmol) compared with lower quintiles (P < .05 and P < .01, respectively). Hyperinsulinemic microalbuminuria (simultaneous presence of fasting insulin > or = 114.0 pmol/L and ACR > or = 3.22 mg/mmol) markedly increased the risk of CHD mortality (12.5%, P < .001) and all CHD events (18.8%, P < .001) compared with normoinsulinemic subjects without microalbuminuria (2.2% and 5.8%, respectively). In univariate logistic regression analyses, hyperinsulinemic microalbuminuria was a strong predictor of both CHD death (odds ratio [OR], 5.93; P < .001) and all CHD events (OR, 3.39; P = .002). Multivariate logistic regression analyses were also performed, including sex, current smoking, waist-hip ratio, systolic blood pressure, and HDL cholesterol, with insulin, ACR, or both as independent variables. Even after adjustment for these variables, hyperinsulinemic microalbuminuria remained a strong predictor of CHD death (OR, 7.91; P < .001) and all CHD events (OR, 2.95; P = .014). The group with hyperinsulinemic microalbuminuria was characterized by the most adversely affected risk factor pattern (high triglycerides > or = 2.3 mmol/L, low HDL cholesterol < or = 0.9 mmol/L in men and < or = 1.20 mmol/L in women, and hypertension). CONCLUSIONS Simultaneous occurrence of hyperinsulinemia and microalbuminuria identifies a group of subjects with a highly increased risk for CHD in elderly nondiabetic subjects.

[1]  M. Laakso,et al.  NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects , 1994, Diabetes.

[2]  L. Niskanen,et al.  Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. , 1993, Metabolism: clinical and experimental.

[3]  M. Laakso,et al.  How good a marker is insulin level for insulin resistance? , 1993, American journal of epidemiology.

[4]  M. Feinglos,et al.  Screening for Microalbuminuria: A comparison of single sample methods of collection and techniques of albumin analysis , 1992, Diabetes Care.

[5]  K. Borch-Johnsen,et al.  Microalbuminuria: Implications for micro- and macrovascular disease , 1992, Diabetes Care.

[6]  A. Fitzgerald,et al.  Prospective Study of Microalbuminuria as Predictor of Mortality in NIDDM , 1992, Diabetes.

[7]  V. Salomaa,et al.  Acute myocardial infarction (AMI) in Finland--baseline data from the FINMONICA AMI register in 1983-1985. , 1992, European heart journal.

[8]  S. Nielsen,et al.  Microalbuminuria in non-insulin-dependent diabetes. , 1992, Clinical nephrology.

[9]  M. Laakso,et al.  Asymptomatic atherosclerosis and insulin resistance. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  M. Laakso,et al.  Asymptomatic hyperglycemia and cardiovascular risk factors in the elderly. , 1991, Atherosclerosis.

[11]  E. Ravussin,et al.  Racial differences in the relation between blood pressure and insulin resistance. , 1991, The New England journal of medicine.

[12]  M. Laakso,et al.  Prevalence of Diabetes and Impaired Glucose Tolerance in Elderly Subjects and Their Association With Obesity and Family History of Diabete , 1990, Diabetes Care.

[13]  H. Parving,et al.  Glomerular Structure and Function in Diabetic Nephropathy: Early to Advanced Stages , 1990, Diabetes.

[14]  S. Haffner,et al.  Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? , 1990, Arteriosclerosis.

[15]  R. Stout,et al.  Insulin and atheroma. 20-yr perspective. , 1990, Diabetes care.

[16]  C. Mogensen,et al.  Microalbuminuria as predictor of increased mortality in elderly people. , 1990, BMJ.

[17]  R. Gelfand,et al.  Skeletal Muscle Proteolysis in Rats With Acute Streptozocin-Induced Diabetes , 1989, Diabetes.

[18]  A. Schmidt,et al.  Relationship of Sulfated Glycosaminoglycans and Cholesterol Content in Normaland Arteriosclerotic Human Aorta , 1989, Arteriosclerosis.

[19]  W. Krone,et al.  Opposite Effects of Insulin and Catecholamines on LDL-Receptor Activity in Human Mononuclear Leukocytes , 1988, Diabetes.

[20]  C. Jackson,et al.  MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.

[21]  H. Dybdahl,et al.  Diabetic macroangiopathy. Quantitative histopathological studies of the extramural coronary arteries from type 2 (non-insulin-dependent) diabetic patients. , 1987, Diabetologia.

[22]  G. Reaven,et al.  Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. , 1987, The Journal of clinical endocrinology and metabolism.

[23]  R. Spiro,et al.  Studies on Macromolecular Components of Human Glomerular Basement Membrane and Alterations in Diabetes: Decreased Levels of Heparan Sulfate Proteoglycan and Laminin , 1987, Diabetes.

[24]  C. Hagengruber,et al.  Automated determination of urinary creatinine without sample dilution: theory and practice. , 1986, Clinical Chemistry.

[25]  P. Harper,et al.  Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial-cell proliferation. , 1985, The American journal of pathology.

[26]  H. Halkin,et al.  Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. , 1985, The Journal of clinical investigation.

[27]  C. Mogensen,et al.  Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. , 1984, The New England journal of medicine.

[28]  J. Ziegenhorn,et al.  Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. , 1983, Clinical chemistry.

[29]  H. Keen,et al.  MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS , 1982, The Lancet.

[30]  Ronald J. Prineas,et al.  The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification , 1982 .

[31]  E. Voutilainen,et al.  Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol. , 1981, Scandinavian journal of clinical and laboratory investigation.

[32]  T. Welborn,et al.  Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations , 1979, Diabetes Care.

[33]  H. Parving,et al.  Increased urinary albumin-excretion rate in benign essential hypertension. , 1974, Lancet.

[34]  A. Wahlefeld.  Triglycerides Determination after Enzymatic Hydrolysis , 1974 .

[35]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.

[36]  Hans Ulrich Bergmeyer,et al.  Methods of Enzymatic Analysis , 2019 .

[37]  P. J. Randle,et al.  Immunoassay of insulin with insulin antibody preciptate. , 1963, Lancet.